Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
This study is ongoing, but not recruiting participants.
National Cancer Institute (NCI)
First Posted: March 24, 2010
Last Update Posted: July 2, 2017
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )